<DOC>
	<DOCNO>NCT01392196</DOCNO>
	<brief_summary>This feasibility study enrol 40 patient Australia Europe . The primary aim study demonstrate renal denervation Symplicity Catheter safe determine evidence response renal denervation patient Heart Failure .</brief_summary>
	<brief_title>Renal Denervation Patients With Chronic Heart Failure &amp; Renal Impairment Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Heart Failure patient NYHA Class II III Renal Impairment Left Ventricular Ejection Function &lt; 40 % GFR 30 75 mL/min/1.73m2 Optimal stable medical therapy Renal artery anatomy must eligible treatment determined Angiography , History prior renal artery intervention Single function kidney . Myocardial Infarction , unstable angina pectoris cerebrovascular Accident within 3 month Systolic BP &lt; 90 mmHG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Renal Impairment</keyword>
</DOC>